1. Home
  2. KALU vs REPL Comparison

KALU vs REPL Comparison

Compare KALU & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALU
  • REPL
  • Stock Information
  • Founded
  • KALU 1946
  • REPL 2015
  • Country
  • KALU United States
  • REPL United States
  • Employees
  • KALU N/A
  • REPL N/A
  • Industry
  • KALU Metal Fabrications
  • REPL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KALU Industrials
  • REPL Health Care
  • Exchange
  • KALU Nasdaq
  • REPL Nasdaq
  • Market Cap
  • KALU 1.1B
  • REPL 897.3M
  • IPO Year
  • KALU 1991
  • REPL 2018
  • Fundamental
  • Price
  • KALU $70.00
  • REPL $11.20
  • Analyst Decision
  • KALU Buy
  • REPL Strong Buy
  • Analyst Count
  • KALU 3
  • REPL 6
  • Target Price
  • KALU $82.33
  • REPL $17.50
  • AVG Volume (30 Days)
  • KALU 100.1K
  • REPL 741.0K
  • Earning Date
  • KALU 02-19-2025
  • REPL 02-06-2025
  • Dividend Yield
  • KALU 4.46%
  • REPL N/A
  • EPS Growth
  • KALU 252.66
  • REPL N/A
  • EPS
  • KALU 2.90
  • REPL N/A
  • Revenue
  • KALU $2,980,300,000.00
  • REPL N/A
  • Revenue This Year
  • KALU N/A
  • REPL N/A
  • Revenue Next Year
  • KALU $6.84
  • REPL $300.41
  • P/E Ratio
  • KALU $23.78
  • REPL N/A
  • Revenue Growth
  • KALU N/A
  • REPL N/A
  • 52 Week Low
  • KALU $59.52
  • REPL $4.92
  • 52 Week High
  • KALU $102.42
  • REPL $17.00
  • Technical
  • Relative Strength Index (RSI)
  • KALU 31.87
  • REPL 38.70
  • Support Level
  • KALU $69.37
  • REPL $11.78
  • Resistance Level
  • KALU $72.46
  • REPL $12.83
  • Average True Range (ATR)
  • KALU 2.39
  • REPL 0.85
  • MACD
  • KALU -0.06
  • REPL -0.09
  • Stochastic Oscillator
  • KALU 26.12
  • REPL 5.98

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from United States.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

Share on Social Networks: